Skip to main content

Avricore Health looks to continue positive growth in 2023 after success in 2022

Avricore Health CEO Hector Bremner joined Proactive's Steve Darling with an update on the company's 2022 performance and the goals it has set for 2023.

Bremner told Proactive more about Avricore's key HealthTab offering and the scaling it saw in 2022. He also shared his vision for 2023, which includes further expansion of HealthTab with current partners, international expansion, and revenue growth and profitability.

Contact Details

Proactive Studio

+1 347-449-0879

na-editorial@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.11
+5.25 (2.56%)
AAPL  264.58
+4.00 (1.54%)
AMD  200.15
-3.22 (-1.58%)
BAC  53.06
+0.29 (0.55%)
GOOG  314.90
+11.34 (3.74%)
META  655.66
+10.88 (1.69%)
MSFT  397.23
-1.23 (-0.31%)
NVDA  189.82
+1.92 (1.02%)
ORCL  148.08
-8.46 (-5.40%)
TSLA  411.82
+0.11 (0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.